arrow
G

Gregory J. Cost

Casebia Therapeutics
H指数:33
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders

工程化调节性T细胞治疗IPEX及其他自身免疫性疾病的疗效与安全性评估

2026-03-130
PRE
Integration of therapeutic cargo into the human genome with programmable type V-K CAST

利用可编程V-K型CAST将治疗性载荷整合到人类基因组中

2025-03-131
OA
AFNT-212: A TRAC-knocked-in KRASG12D-specific TCR-T cell product enhanced with CD8αß and a chimeric cytokine receptor for treatment of solid cancers
2024-03-220
PRE
Non-viral engineered T cell therapy specific for the hotspot mutation p53 R175H that integrates signal 1 (TCR), signal 2 ( co-stimulation) and signal 3 (cytokine) and co-opts FasL-dependent apoptosis to achieve a coordinated antitumor CD4/8 T cell response
2024-03-220
PRE
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability
2023-06-012
OAAI
Correction of the Sickle-Cell Disease Mutation in Human Hematopoietic Stem/Progenitor Cells
2015-05-010
OAAI